CXCL12 and B-cell chronic lymphocytic leukemia: Burger et al. reported that T140 and its analogs inhibited the activity, chemotaxis, and migration of CLL cells in the bone marrow stroma, with the mechanism involving the disruption of CXCL12-induced STAT3 and MAPK phosphorylation [169] (Table 1).